Literature DB >> 15234630

The truth about quality: medical usefulness and analytical reliability of laboratory tests.

James O Westgard1, Teresa Darcy.   

Abstract

BACKGROUND: In this age of evidence-based medicine, nothing is more important than the quality of laboratory tests. It is commonly thought that laboratory tests provide two-thirds to three-fourths of the information used for making medical decisions. If so, test results had better tell the truth about what is happening with our patients.
METHODS: The age-old "truth standard" for the quality of evidence describes three dimensions that are important-a test should tell the truth, the whole truth, and nothing but the truth. This three-dimensional model can be used to characterize the clinical and analytical reliability of laboratory tests and guide the translation of outcome criteria, or quality goals, into practical specifications for method performance.
RESULTS: Clinical reliability, or medical usefulness, should assess the correctness of patient classifications based on stated test interpretation guidelines, taking into account the precision and accuracy of the laboratory method, and allowing for the known within-subject biologic variation and the QC needed to detect method instability. Analytical reliability should assess the correctness of a test result based on a stated error limit, taking into account the precision and accuracy of the method and allowing for the QC necessary to detect method instability. These assessments challenge the reliability of current tests for cholesterol, glucose, and glycated hemoglobin in the implementation of U.S. national clinical guidelines.
CONCLUSIONS: Evidence-based medicine must employ scientific methodology for translating test interpretation guidelines into practical, bench-level, operating specifications for the imprecision and inaccuracy allowable for a method and the QC necessary to detect method instability.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15234630     DOI: 10.1016/j.cccn.2003.12.034

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

1.  Validation of Method Performance of pH, PCO2, PO2, Na(+), K(+) of Cobas b121 ABG Analyser.

Authors:  Sunil Kumar Nanda; Lopamudra Ray; Asha Dinakaran
Journal:  J Clin Diagn Res       Date:  2014-06-20

Review 2.  Harmonization of blood-based indicators of iron status: making the hard work matter.

Authors:  Andrew N Hoofnagle
Journal:  Am J Clin Nutr       Date:  2017-10-25       Impact factor: 7.045

Review 3.  Introduction to workshop on iron screening and supplementation in iron-replete pregnant women and young children.

Authors:  Christine L Taylor; Patsy M Brannon
Journal:  Am J Clin Nutr       Date:  2017-10-25       Impact factor: 7.045

4.  Differences in GlycA and lipoprotein particle parameters may help distinguish acute kawasaki disease from other febrile illnesses in children.

Authors:  Margery A Connelly; Chisato Shimizu; Deborah A Winegar; Irina Shalaurova; Ray Pourfarzib; James D Otvos; John T Kanegaye; Adriana H Tremoulet; Jane C Burns
Journal:  BMC Pediatr       Date:  2016-09-05       Impact factor: 2.125

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.